Loading...
STERIS plc
STE•NYSE
HealthcareMedical - Devices
$243.73
$0.15(0.06%)
STERIS plc (STE) Financial Performance & Statements
Review STERIS plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
3.65%
↑ 3.65%
Operating Income Growth
211.77%
↑ 211.77%
Net Income Growth
253.40%
↑ 253.40%
Operating Cash Flow Growth
28.58%
↑ 28.58%
Operating Margin
15.87%
↑ 15.87%
Gross Margin
45.31%
↑ 45.31%
Net Profit Margin
11.26%
↑ 11.26%
ROE
9.46%
↑ 9.46%
ROIC
9.50%
↑ 9.50%
STERIS plc (STE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for STERIS plc stock.
Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
---|---|---|---|---|
Revenue | $1.37B | $1.33B | $1.28B | $1.42B |
Cost of Revenue | $760.24M | $750.12M | $706.83M | $768.73M |
Gross Profit | $610.33M | $578.79M | $572.67M | $650.66M |
Gross Profit Ratio | $0.45 | $0.44 | $0.45 | $0.46 |
R&D Expenses | $27.36M | $27.03M | $25.57M | $27.46M |
SG&A Expenses | $335.45M | $329.30M | $305.16M | $309.06M |
Operating Expenses | $365.04M | $359.13M | $330.73M | $404.29M |
Total Costs & Expenses | $1.13B | $1.11B | $1.04B | $1.17B |
Interest Income | $2.43M | $1.13M | $1.31M | $6.33M |
Interest Expense | $19.09M | $19.67M | $30.38M | $36.10M |
Depreciation & Amortization | $125.91M | $115.25M | $112.70M | $66.61M |
EBITDA | $373.75M | $329.81M | $318.34M | $333.82M |
EBITDA Ratio | $0.27 | $0.25 | $0.25 | $0.24 |
Operating Income | $245.29M | $219.67M | $241.94M | $246.38M |
Operating Income Ratio | $0.18 | $0.17 | $0.19 | $0.17 |
Other Income/Expenses (Net) | -$16.55M | -$24.77M | -$10.27M | -$29.76M |
Income Before Tax | $228.75M | $194.89M | $175.26M | $190.57M |
Income Before Tax Ratio | $0.17 | $0.15 | $0.14 | $0.13 |
Income Tax Expense | $55.38M | $43.51M | $35.31M | $37.28M |
Net Income | $173.53M | $150.03M | $145.40M | -$1.38M |
Net Income Ratio | $0.13 | $0.11 | $0.11 | -$0.001 |
EPS | $1.75 | $1.52 | $1.47 | -$0.01 |
Diluted EPS | $1.75 | $1.51 | $1.46 | -$0.01 |
Weighted Avg Shares Outstanding | $98.49M | $98.87M | $98.87M | $98.85M |
Weighted Avg Shares Outstanding (Diluted) | $98.94M | $99.20M | $99.38M | $98.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan